BACKGROUND: Hepatocellular carcinoma (HCC) significantly contributes to the global burden of cancer. Liver cancer is the third most frequent cause of cancer-related death with HCC representing more than 90% of primary liver cancers. The majority of patients are not only affected by the malignant disease but do also suffer from chronic liver disease. Therefore, several factors impact on the prognosis of patients with HCC, including tumor-related factors, liver function and patient-related factors such as performance status and other comorbidities. The nutritional status is of high significance for the patients' performance status, the tolerance of tumor-targeting therapy and the prognosis of cancer of any type and is specially referenced in HCC. This overview is on current concepts on the role of nutritional factors in hepatocarcinogenesis and the role of nutrition in patients affected by HCC. SUMMARY: Nutritional status and composition of diet are relevant factors related to the risk of HCC. They also have an important role concerning the prognosis of patients with HCC. Besides risk factors, several macro- and micronutrient components have been found to be inversely correlated with the risk of HCC. To prevent disease progression to liver cirrhosis or HCC in patients with nonalcoholic steatohepatitis, it is crucial to optimize the metabolic state. KEY MESSAGE AND PRACTICAL IMPLICATION: Evidence from well-designed prospective interventional trials with the aim to reduce the HCC incidence or to prolong survival in patients with HCC based on nutritional modification is still to be generated.
BACKGROUND:Hepatocellular carcinoma (HCC) significantly contributes to the global burden of cancer. Liver cancer is the third most frequent cause of cancer-related death with HCC representing more than 90% of primary liver cancers. The majority of patients are not only affected by the malignant disease but do also suffer from chronic liver disease. Therefore, several factors impact on the prognosis of patients with HCC, including tumor-related factors, liver function and patient-related factors such as performance status and other comorbidities. The nutritional status is of high significance for the patients' performance status, the tolerance of tumor-targeting therapy and the prognosis of cancer of any type and is specially referenced in HCC. This overview is on current concepts on the role of nutritional factors in hepatocarcinogenesis and the role of nutrition in patients affected by HCC. SUMMARY: Nutritional status and composition of diet are relevant factors related to the risk of HCC. They also have an important role concerning the prognosis of patients with HCC. Besides risk factors, several macro- and micronutrient components have been found to be inversely correlated with the risk of HCC. To prevent disease progression to liver cirrhosis or HCC in patients with nonalcoholic steatohepatitis, it is crucial to optimize the metabolic state. KEY MESSAGE AND PRACTICAL IMPLICATION: Evidence from well-designed prospective interventional trials with the aim to reduce the HCC incidence or to prolong survival in patients with HCC based on nutritional modification is still to be generated.
Authors: S Hirsch; D Bunout; P de la Maza; H Iturriaga; M Petermann; G Icazar; V Gattas; G Ugarte Journal: JPEN J Parenter Enteral Nutr Date: 1993 Mar-Apr Impact factor: 4.016
Authors: M Rossi; L Lipworth; L Dal Maso; R Talamini; M Montella; J Polesel; J K McLaughlin; M Parpinel; S Franceschi; P Lagiou; C La Vecchia Journal: Ann Oncol Date: 2009-06-23 Impact factor: 32.976
Authors: Aldo J Montano-Loza; Andres Duarte-Rojo; Judith Meza-Junco; Vickie E Baracos; Michael B Sawyer; Jack X Q Pang; Crystal Beaumont; Nina Esfandiari; Robert P Myers Journal: Clin Transl Gastroenterol Date: 2015-07-16 Impact factor: 4.488
Authors: V Fedirko; A Trichopolou; C Bamia; T Duarte-Salles; E Trepo; K Aleksandrova; U Nöthlings; A Lukanova; P Lagiou; P Boffetta; D Trichopoulos; V A Katzke; K Overvad; A Tjønneland; L Hansen; M C Boutron-Ruault; G Fagherazzi; N Bastide; S Panico; S Grioni; P Vineis; D Palli; R Tumino; H B Bueno-de-Mesquita; P H Peeters; G Skeie; D Engeset; C L Parr; P Jakszyn; M J Sánchez; A Barricarte; P Amiano; M Chirlaque; J R Quirós; M Sund; M Werner; E Sonestedt; U Ericson; T J Key; K T Khaw; P Ferrari; I Romieu; E Riboli; M Jenab Journal: Ann Oncol Date: 2013-05-12 Impact factor: 32.976